CTEPH News

August 9, 2019August 9, 2019

Heart Transplant Program at UC San Diego Recognized for 1-year Survival Rate of 98.7%, Best in US

CTEPH News, News

The heart transplant program at the University of California San Diego Health has achieved the best one-year patient survival rate in the U.S., with surgeons working at the Cardiovascular ... Read more

August 2, 2019August 2, 2019

Analyzing Exhaled Breath in Differing Positions May Be ‘Simple and Safe’ Way of Monitoring CTEPH

CTEPH News, News, PH News

Analysis of gas exhaled in differing positions, like sitting or laying flat, could be a noninvasive and simple alternative to right heart catheterization in evaluating and managing people with chronic ... Read more

August 1, 2019August 2, 2019

Adempas May Improve Endothelial Cells’ Function in CTEPH, Study Suggests

CTEPH News, News

The vasodilator Adempas (riociguat) increases the ability of endothelial progenitor cells to halt vascular remodeling and enhance formation of new blood vessels in chronic thromboembolic pulmonary hypertension (CTEPH), according to a new ... Read more

July 26, 2019July 26, 2019

Specific Heart Rhythm Parameters Help Predict PH, Study Suggests

CTEPH News, News, PAH News, PH News

The heart rhythm of patients with pulmonary hypertension (PH) has limited ability to adjust to changes, compared to unaffected people used as controls in a new pilot study. The ... Read more

June 20, 2019June 27, 2019

Balloon Pulmonary Angioplasty and Adempas Both Effective for Inoperable CTEPH, Analysis Shows

CTEPH News, News

A new meta-analysis assessing balloon pulmonary angioplasty (BPA) and Adempas (riociguat) for treating inoperable chronic thromboembolic pulmonary hypertension (CTEPH) found both treatment strategies to be well-tolerated, and able to ... Read more

May 29, 2019May 29, 2019

Bayer US Launches $1 Million Grant Program to Boost Clinical Research into PH

CTEPH News, News, PAH News, PH News

The Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, recently launched by Bayer US, will grant up to $1 million dollars for clinical research into pulmonary hypertension (PH). Spread over two years, ... Read more

May 22, 2019June 3, 2019

Balloon Pulmonary Angioplasty Reduces Sleep Apnea in Patients with CTEPH, Study Shows

CTEPH News, News

Balloon pulmonary angioplasty reduces sleep apnea in chronic thromboembolic pulmonary hypertension (CTEPH) patients, according to a study. The observed improvements further correlated with a better mean pulmonary arterial pressure. ... Read more

March 6, 2019March 12, 2019

Transition from PDE5i to Adempas Without Washout Period Deemed Safe

CTEPH News, News, PAH News, PH News

Transition from phosphodiesterase-5 inhibitors (PDE5i) — such as United Therapeutics’ Adcirca (taladafil) and Pfizer‘s Revatio (sildenafil) — to Bayer‘s Adempas (riociguat), a soluble guanylate cyclase (sGC) stimulator, without a washout period ... Read more

February 21, 2019February 27, 2019

Higher Levels of 2 Autoantibodies Could Help Diagnose CTEPH and PAH, Study Suggests

CTEPH News, News, PAH News

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) have higher serum levels of antibodies against the EDX2 and PHAX proteins, according to research which suggests ... Read more

February 20, 2019February 25, 2019

Balloon Pulmonary Angioplasty Can Shorten CTEPH Patients’ Hospital Stays, Study Reports

CTEPH News, News

Greater experience in balloon pulmonary angioplasty (BPA) enables shorter hospital stays for patients with chronic thromboembolic pulmonary hypertension (CTEPH), reduces use of intensive care, and lowers medical costs while maintaining the ... Read more

Pin It on Pinterest